The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.

At first, the monovalent influenza A (H5N8) vaccine will be tested in two doses, 21 days apart, in adults aged 18–59.

The risk to the public remained low, but people in close contact with dairy cattle may be at an increased risk, the state ...

Santo Domingo, DR — Nineteen tests were positive for the virus in respiratory samples analyzed by the Dr. Defilló National ...

Moderna is preparing to test Health Secretary Robert F. Kennedy Jr.'s tougher vaccine policies with a combination flu-COVID ...

Over the last three weeks there have been a number of cases of groups of dead wild sea birds washing up on shorelines in ...

Highly pathogenic avian influenza is having a deadly effect on Michigan’s eagle population. A 2022 outbreak reduced breeding pairs. Now cases are going up again, and researchers are watching for a ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

HNL Lab Medicine expands self-pay lab test menu, adding virus panels and wellness screenings with no insurance or doctor’s ...

The Arizona Department of Agriculture (AZDA) has confirmed a new detection of H5N1 avian influenza in milk from a Maricopa ...

The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review standards.

The low-cost sensor uses DNA to find diseases like cancer and flu. It works for two months and needs no fridge.